ArticleiScience2024

Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981.

Richa Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.